logo  
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

Retrophin Raises Offer to Acquire Transcept Pharmaceuticals to $4 Per Share

By  +Follow September 19, 2013 8:51AM
Share:
Tickers Mentioned:

Retrophin, Inc. (RTRX) is not giving up on its pursuit to acquire the shares of specialty drug maker Transcept Pharmaceuticals, Inc. (TSPT) that it does not already own.  Last week, Retrophin delivered a letter to the board of directors of Transcept offering to buy the remaining shares for $3.50 each in cash.  The offer was rejected. 

To defend itself from a hostile takeover, Transcept has adopted a shareholder rights plan, often called a “poison pill,” which keeps a shareholder from acquiring more than 4.99 percent of the company.

On Wednesday, Retrophin bumped the offer up to $4.00 per share, with Retrophin chief executive Martin Shkreli sending a letter to the board members of Transcept.

Transcept is focused on development of neuroscience drugs with its only FDA approval being the oral sleep aid Intermezzo (zolpidem tartrate).  Purdue Pharma holds commercialization and development right for Intermezzo in the U.S.  Royalty revenue for Transcept from Intermezzo in the first six months of 2013 was $1.0 million, up from $500,000 in the year prior period. 

Net loss for the six months ended June 30, 2013 was approximately $17.2 million, or $0.92 per share, versus a net loss of approximately $10.3 million, or $0.67 per share, for the six months of 2012.

Retrophin has four drugs in its pipeline with RE-021 the only one in the clinical stage, being researched in a mid-stage trial for Focal Segmental Glomerulosclerosis, a disease that can cause nephrotic syndrome in children and kidney failure in adults.  The company’s other compounds are targeting hard-to-treat diseases like Pantothenate Kinase-Associated Neurodegeneration (PKAN) and Duchenne Muscular Dystrophy.

In recent weeks, three major shareholders of Transcept have publicly stated their disapproval of Transcept’s current strategy.  Activist investor Peter Collery of SC Fundamental LLC, which owns a 6.7-percent stake in Transcept, sent a letter to Transcept chief executive, president and director Glenn Oclassen (read the SEC filing) saying that the company needs to use $60 million of its cash to conduct a share repurchase to build value, not pursue “simply wrongheaded,” (but unnamed) projects.

Collery didn’t hold back much in expressing his feelings toward Transept management.  Such as:

“I should note how troubled we are by your presumption that the company’s money is yours to do with as you see fit. You and your fellow directors have a fiduciary duty to company shareholders.”

And...

“I’d like, in closing, also to express my displeasure with the company’s recent grant of nearly 600,000 management stock options with a strike price of $2.93 per share. As described above, the company’s shares may have a current realizable value of $5 or so. Were Transcept to implement a buyback program, that value might rise to $6. Essentially no management skill would be required to realize these values. That the shares trade for less than $3 is a function of shareholders’ distrust of management. It is incredible that management should be granted undervalued stock options as a “reward” for having created that distrust and I would expect that an inquiry into the deliberations surrounding this recent option grant, and particularly, the suitability of the strike price would be quite interesting.”

Roumell Asset Management, LLC, the largest Transcept shareholder at 12.3 percent of the company, has also filed a 13D with the SEC criticizing the management and demanding a share buy-back plan, not an unidentified acquisition.

The new proposal by Retrophin offers to buy Transcept at a 20-percent premium to Tuesday’s closing price.  The price is still lower than the $6 mark that Collery believes can be attained by performing a share repurchase, but this is a little to-may-toes/to-ma-toes because a merged company could benefit similarly, so investors will have to see where the support falls with the new proposal.

“Our proposal represents an attractive premium to Transcept’s trading performance, and we believe that the proposal offers a compelling opportunity for Transcept’s stockholders, particularly in light of Transcept’s risky and controversial acquisition strategy,” stated Martin Shkreli, Chief Executive Officer of Retrophin. “We hope that Transcept’s Board of Directors will respect its stockholders’ wishes and quickly commence discussions with us regarding the proposed transaction.”

Retrophin wants a transaction to be entered into by the end of September.

Shares of TSPT are down about 18 percent in 2013 thanks to a run-up from lows of $2.52 late in August with the acquisition chatter.  At lows, the stock was off about 40 percent.  Shares rose by 8 percent in Wednesday trading to close at $3.59.  In extended trading, shares rose to $3.98.  Retrophin shares edged up about 1 percent on the day to $6.88.  Shares have more than doubled in 2013.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions.


Signup for our daily newsletter and get our best articles emailed right to you!

Results for rtrx
Stockaholics
20 Dec 14 09:50:42
Platinum Memberships Rose, After 528% Gains On Penny Stocks, In One Month! Big Update: http://t.co/2W3yKD2d5Q $RTRX $CPST $TGTX
chartguy89
20 Dec 14 05:55:08
RTRX +5.42% Stock Charts $RTRX Retrophin Inc. (NASDAQ) Last Updated: 12/20/2014 07:55:08 RTRX Stock Chart - 1 http://t.co/EoMa54yiIs
Stockaholics
19 Dec 14 23:44:05
Platinum Memberships Rose, After 528% Gains On Penny Stocks, In One Month! Big Update: http://t.co/2W3yKD2d5Q $RTRX $CPST $TGTX
Stockaholics
19 Dec 14 15:49:14
Platinum Memberships Rose, After 528% Gains On Penny Stocks, In One Month! Big Update: http://t.co/2W3yKD2d5Q $RTRX $CPST $TGTX
Zachary Prensky
19 Dec 14 12:54:29
Selling $RTRX $NLNK $ASPX $AEGR and last mo's $SGGH means cash at all time high of 35% Need more ideas guys!
nixon786
19 Dec 14 12:53:57
RT @Emory_R: Strange action in $RTRX big volume http://t.co/btP1Xjenti
zipjet
19 Dec 14 12:53:19
$RTRX 80k shares bought in 2 minutes jumping stock 50 cents - big buyer still active
Emory Redd
19 Dec 14 12:53:19
Strange action in $RTRX big volume http://t.co/btP1Xjenti
BioInvestor
19 Dec 14 12:05:52
Roughly 1.5MM shares short in $RTRX during last 3 months are under water. The run up could be tax loss covering by shorts. A short squeeze?
DailyStockPicks
19 Dec 14 12:01:26
$ECIG breakout up 50%, target $0.50 $WMT ex-CEO on BOD $JIVE $RTRX $FEYE $OREX traders read: http://t.co/RB85WZsWYu http://t.co/xi3978GuDs
Scott Thomas
19 Dec 14 10:46:08
Heck of a week for $RTRX . Just under $10 ....to over $13.30
BioInvestor
19 Dec 14 09:38:03
Sold 30 call contracts of $RTRX strike 20, Jun'15
Rowena Kaminski
19 Dec 14 09:18:56
RT @stocksecret101: Make Money With BitCoin Every Single Day More Info Here http://t.co/SVqoMlijqL .. $RTRX $CPST $TGTX
Penny Stock Secret
19 Dec 14 09:18:30
Make Money With BitCoin Every Single Day More Info Here http://t.co/SVqoMlijqL .. $RTRX $CPST $TGTX
WhiteCoatMafia
19 Dec 14 09:15:37
$RTRX finally changing direction. http://t.co/KRLexk1mB9
Stockaholics
19 Dec 14 09:11:26
Platinum Memberships Rose, After 528% Gains On Penny Stocks, In One Month! Big Update: http://t.co/2W3yKD2d5Q $RTRX $CPST $TGTX
Zachary Prensky
19 Dec 14 09:07:07
Sold all my $RTRX long option positions.
kevins stocks
19 Dec 14 08:59:09
RT @pawcio2009: $aegr down 68% for the year $cytr down 63% $gale down 68% $dndn down 99% $rtrx up 78% Who gets the vote for worse CEO? WTF?…
Thug Biotech Analyst
19 Dec 14 08:31:19
$RTRX tho
Thug Biotech Analyst
18 Dec 14 16:45:45
RT @pawcio2009: $aegr down 68% for the year $cytr down 63% $gale down 68% $dndn down 99% $rtrx up 78% Who gets the vote for worse CEO? WTF?…
Brandon
18 Dec 14 15:51:19
$GPRO weak open r/g $XNY $XNCR $RTRX $LJPC $FMD $CUBA $ADX looking for the s/s when it presents #stocks #daytrading #smallcaps #finance
Cadbioinvest
18 Dec 14 15:46:44
@MartinShkreli @adamfeuerstein Being nominated in first place is laughable. You created value despite all the crap. $RTRX
Bio_Tech_Boss
18 Dec 14 15:23:05
RT @pawcio2009: $aegr down 68% for the year $cytr down 63% $gale down 68% $dndn down 99% $rtrx up 78% Who gets the vote for worse CEO? WTF?…
Clay Stribling
18 Dec 14 14:33:53
RT @pawcio2009: $aegr down 68% for the year $cytr down 63% $gale down 68% $dndn down 99% $rtrx up 78% Who gets the vote for worse CEO? WTF?…
Patrick
18 Dec 14 13:40:24
RT @pawcio2009: $aegr down 68% for the year $cytr down 63% $gale down 68% $dndn down 99% $rtrx up 78% Who gets the vote for worse CEO? WTF?…
BioTurdCEO
18 Dec 14 13:21:26
RT @pawcio2009: $aegr down 68% for the year $cytr down 63% $gale down 68% $dndn down 99% $rtrx up 78% Who gets the vote for worse CEO? WTF?…
Martin Shkreli
18 Dec 14 13:18:08
RT @pawcio2009: $aegr down 68% for the year $cytr down 63% $gale down 68% $dndn down 99% $rtrx up 78% Who gets the vote for worse CEO? WTF?…
V
18 Dec 14 12:53:45
Sold more $rtrx now at 1/2 position
Yu Zhu
18 Dec 14 12:43:26
RT @MartinShkreli: $RTRX +84% YTD, but u know i don't think "the rules", which are what... kissing @adamfeuerstein 's ass and pretending $T…
1Guille1Trader
18 Dec 14 12:28:04
Potential drops for tomorrow that I'm not trading: $XNCR, $CERS, $RDUS, $RTRX, $AXX, $MBT, $APP, $BBX, $ZAGG, $AGEN
Brandon
18 Dec 14 11:56:54
$RTRX stalking
Thug Biotech Analyst
18 Dec 14 10:21:26
RT @sheff2d2: @MartinShkreli There are dozens of people who worked with and for Martin at $RTRX for whom he was, and is, the most inspiring…
Sheff2D2
18 Dec 14 10:17:19
@MartinShkreli There are dozens of people who worked with and for Martin at $RTRX for whom he was, and is, the most inspiring boss ever
Pawcio
18 Dec 14 10:03:57
$aegr down 68% for the year $cytr down 63% $gale down 68% $dndn down 99% $rtrx up 78% Who gets the vote for worse CEO? WTF? Are u kidding?
Stockaholics
18 Dec 14 10:03:43
Platinum Memberships Rose, After 528% Gains On Penny Stocks, In One Month! Big Update: http://t.co/2W3yKD2d5Q $RTRX $CPST $TGTX
Thug Biotech Analyst
18 Dec 14 09:37:26
RT @MartinShkreli: $RTRX +84% YTD, but u know i don't think "the rules", which are what... kissing @adamfeuerstein 's ass and pretending $T…
thisJustIn__
18 Dec 14 08:37:23
GO $RTRX! http://t.co/8kKJ4pA2Ih
Martin Shkreli
18 Dec 14 08:33:35
$RTRX +84% YTD, but u know i don't think "the rules", which are what... kissing @adamfeuerstein 's ass and pretending $TST=$NYT? apply to me
Class Actions News
18 Dec 14 08:30:10
$RTRX sued by investors re CEO alleged unauthorized stock grants http://t.co/fLEffsHKYv
TosTos
18 Dec 14 08:29:40
I didn't like all @MartinShkreli did, BUT he's nowhere close to the worst biotech CEO of '14. He shdn't even be a nominee. $RTRX
V
18 Dec 14 07:57:12
I'm out $sny and sold a little $rtrx
weltvermesser ن
18 Dec 14 07:48:46
.@adamfeuerstein strange "worst Biotech CEO vote" $DNDN = shareholders lost all their money ; $RTRX = still a nice ROI (cc. @MartinShkreli )
Raj R
18 Dec 14 07:26:41
RT @AceOfSpades2007: Congrats @MartinShkreli, you made it! $RTRX
Andrew Colburn
18 Dec 14 07:13:14
Congrats @MartinShkreli, you made it! $RTRX
Catspaw
18 Dec 14 07:03:36
@given2tweet wrong stock, $rtrx
ProTradersNews
18 Dec 14 05:53:05
$RTRX $DSX: Notable Moves: Retrophin (NASDAQ:RTRX), FX Energy Inc ... http://t.co/dSchTTDbAy http://t.co/wuFA0AJlYi
Stockaholics
18 Dec 14 05:30:36
Platinum Memberships Rose, After 528% Gains On Penny Stocks, In One Month! Big Update: http://t.co/2W3yKD2d5Q $RTRX $CPST $TGTX
stt2318
18 Dec 14 05:03:04
Some extended charts Im watching: $ABCO $ADXS $RCII $MEG $RTRX $SPLS $CUBA
White Rabbit
18 Dec 14 04:14:33
$$$$$$ Money $RTRX $$$$ RT @youngbuck CONGRATS TO BIG BRA @50cent !!! IM SO #Motivated......SURROUNDED BY THIS KIND http://t.co/PdqGUXzOP2
Stockaholics
17 Dec 14 23:18:01
Platinum Memberships Rose, After 528% Gains On Penny Stocks, In One Month! Big Update: http://t.co/2W3yKD2d5Q $RTRX $CPST $TGTX
				
				
By  +Follow September 19, 2013 8:51AM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.